 PTP1B is a negative regulator of the insulin signaling pathway and is considered a promising potential therapeutic target, in particular for treatment of type 2 diabetes.It has also been implicated in the development of breast cancer and has been explored as a potential therapeutic target in that avenue as well.PTP1B was first isolated from a human placental protein extract, but it is expressed in many tissues.